NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Solid Tumor
Date of first enrollment	19/11/2012
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : LY2157299 INN of investigational material : Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : 80 or 150 milligrams of LY2157299 administered orally, twice daily for 14 days, followed by 14 days with no study drug.

Outcome(s)

Primary Outcome
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria	- Have solid tumor. - Have adequate hematologic, hepatic and renal function. - Have a performance status of higher than or equal to 1 on the Eastern Cooperative Oncology Group scale. - Able to swallow tablets.
Exclude criteria